NCT05513833 School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Kentucky
| NCT ID | NCT05513833 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Arkansas |
| Condition | Hearing Loss |
| Study Type | INTERVENTIONAL |
| Enrollment | 18,000 participants |
| Start Date | 2022-09-01 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 18,000 participants in total. It began in 2022-09-01 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This trial will evaluate a multilevel intervention (STAR model) that combines mobile health (mHealth) hearing screening tools with telemedicine technology for specialty care access in rural Kentucky schools. An initial version of the model was used in rural Alaska where telemedicine-based specialty referral improved both proportion of children receiving follow-up and time to follow-up. The refined STAR model will utilize an enhanced mHealth screening protocol that includes tympanometry for the detection of middle ear disease. The STAR model will also include a specialty telemedicine referral process in schools for children who refer school screening.
Eligibility Criteria
Inclusion Criteria: * Enrolled in school in one of the 14 participating counties * Initial entry into elementary school * Eligible regardless of age, gender, race, or ethnicity Exclusion Criteria: • N/A
Contact & Investigator
Matt Bush, MD, PhD, MBA
PRINCIPAL INVESTIGATOR
University of Kentucky
Frequently Asked Questions
Who can join the NCT05513833 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 11 Years, studying Hearing Loss. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05513833 currently recruiting?
Yes, NCT05513833 is actively recruiting participants. Contact the research team at sdemmett@uams.edu for enrollment information.
Where is the NCT05513833 trial being conducted?
This trial is being conducted at Lexington, United States.
Who is sponsoring the NCT05513833 clinical trial?
NCT05513833 is sponsored by University of Arkansas. The principal investigator is Matt Bush, MD, PhD, MBA at University of Kentucky. The trial plans to enroll 18,000 participants.